Celgene Palidomide: CC-4047-BRN-001: A Phase 2 Clinical Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults with Recurrent or Progressive Primary Brain Tumors

  • Fangusaro, Jason R (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date6/28/17 → 8/31/50

Funding

  • Celgene Corporation